This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: October 14, 2022
Source: https://www.ipsen.com/press-releases/ipsen-to-acquire-epizyme-expanding-its-portfolio-in-oncology/
Reason: Acquired by Ipsen
Last recorded trade on: October 14, 2022
Source: https://www.ipsen.com/press-releases/ipsen-to-acquire-epizyme-expanding-its-portfolio-in-oncology/
Epizyme
EPZM
1,33 €
Share price
0.00%
Change (1 day)
-66.23%
Change (1 year)
Categories
Earnings for Epizyme (EPZM)
Earnings in 2022 (TTM): -€0.19 Billion
According to Epizyme's latest financial reports the company's current earnings are €53 Million. In 2021 the company made an earning of -€0.21 Billion a decrease over its 2020 earnings that were of -€0.21 Billion.
Earnings history for Epizyme from 2012 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | -€0.19 Billion | -10.15% |
| 2021 | -€0.21 Billion | 0.63% |
| 2020 | -€0.21 Billion | 32.62% |
| 2019 | -€0.16 Billion | 32.74% |
| 2018 | -€0.12 Billion | -6.38% |
| 2017 | -€0.13 Billion | 22.37% |
| 2016 | -€0.11 Billion | -15.63% |
| 2015 | -€0.12 Billion | 140.78% |
| 2014 | -€49.73 Million | 1660.47% |
| 2013 | -€2.83 Million | 307.16% |
| 2012 | -€0.7 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -€0.72 Billion | 330.61% | 🇺🇸 USA |
 | €12.32 B | -7,529.44% | 🇨🇭 Switzerland |
 | €3.96 B | -2,493.62% | 🇬🇧 UK |
 | €6.33 B | -3,919.84% | 🇺🇸 USA |